The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study - PubMed (original) (raw)

Multicenter Study

The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study

Andreas Festa et al. Diabetes. 2006 Apr.

Abstract

Data from the UKPDS (U.K. Prospective Diabetes Study) indicate a continuous decline in beta-cell function in patients with type 2 diabetes. We studied longitudinal changes in beta-cell function (follow-up of 5.2 years) in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and type 2 diabetes, using acute insulin response (AIR) and insulin sensitivity index (S(i)) from a frequently sampled intravenous glucose tolerance test among African-American, Hispanic, and non-Hispanic white subjects aged 40-69 years. At baseline, decreasing levels of both S(i) and AIR (either unadjusted or adjusted for S(i)) mirrored deteriorating glucose tolerance status at baseline and at follow-up. A different pattern was found with respect to longitudinal changes; S(i) declined in each glucose tolerance category, ranging from -0.81 x10(-4) min(-1) x muU(-1) x ml(-1) in NGT at baseline and NGT at follow-up (NGT/NGT) to -1.06 x10(-4) in NGT/diabetes, whereas the directional change in AIR principally determined the glucose tolerance status at follow-up. In NGT/NGT S(i) decreased by 35% and AIR increased by 34%. Results were similar in each of the three ethnic groups. These data shed light on the natural course of beta-cell function; over 5.2 years, mean insulin sensitivity declined in each glucose tolerance category. The change in AIR, however, principally determined glucose tolerance status at follow-up; NGT was maintained by a compensatory increase in insulin secretion. Failure to increase insulin secretion led to IGT, and a decrease in insulin secretion led to overt diabetes. This data may have important implications for the prevention and treatment of type 2 diabetes.

PubMed Disclaimer

Cited by

Beyond Restrictive: Sleeve Gastrectomy to Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy as a Spectrum of One Single Procedure.
Pereira AM, Moura D, Pereira SS, Andrade S, Almeida RF, Nora M, Monteiro MP, Guimarães M. Pereira AM, et al. Obes Facts. 2024;17(4):364-371. doi: 10.1159/000539104. Epub 2024 May 27. Obes Facts. 2024. PMID: 38801818 Free PMC article.
High-Throughput Methods for the Discovery of Small Molecule Modulators of Pancreatic Beta-Cell Function and Regeneration.
McCarty SM, Clasby MC, Sexton JZ. McCarty SM, et al. Assay Drug Dev Technol. 2024 Apr;22(3):148-159. doi: 10.1089/adt.2023.119. Epub 2024 Mar 25. Assay Drug Dev Technol. 2024. PMID: 38526231 Review.
Obesity, diabetes and their metabolic correlates in middle-aged adults with Down syndrome.
Luchsinger JA, Pang D, Krinsky-McHale SJ, Schupf N, Lee JH, Silverman W, Zigman WB. Luchsinger JA, et al. J Intellect Disabil Res. 2024 Mar;68(3):212-222. doi: 10.1111/jir.13103. Epub 2023 Oct 29. J Intellect Disabil Res. 2024. PMID: 37899501
Noncanonical Regulation of cAMP-Dependent Insulin Secretion and Its Implications in Type 2 Diabetes.
Ramanadham S, Turk J, Bhatnagar S. Ramanadham S, et al. Compr Physiol. 2023 Jun 26;13(3):5023-5049. doi: 10.1002/cphy.c220031. Compr Physiol. 2023. PMID: 37358504 Free PMC article.
A beta cell subset with enhanced insulin secretion and glucose metabolism is reduced in type 2 diabetes.
Rubio-Navarro A, Gómez-Banoy N, Stoll L, Dündar F, Mawla AM, Ma L, Cortada E, Zumbo P, Li A, Reiterer M, Montoya-Oviedo N, Homan EA, Imai N, Gilani A, Liu C, Naji A, Yang B, Chong ACN, Cohen DE, Chen S, Cao J, Pitt GS, Huising MO, Betel D, Lo JC. Rubio-Navarro A, et al. Nat Cell Biol. 2023 Apr;25(4):565-578. doi: 10.1038/s41556-023-01103-1. Epub 2023 Mar 16. Nat Cell Biol. 2023. PMID: 36928765 Free PMC article.

The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study - PubMed (original) (raw)